147 related articles for article (PubMed ID: 27329723)
1. STAT5 induces miR-21 expression in cutaneous T cell lymphoma.
Lindahl LM; Fredholm S; Joseph C; Nielsen BS; Jønson L; Willerslev-Olsen A; Gluud M; Blümel E; Petersen DL; Sibbesen N; Hu T; Nastasi C; Krejsgaard T; Jæhger D; Persson JL; Mongan N; Wasik MA; Litvinov IV; Sasseville D; Koralov SB; Bonefeld CM; Geisler C; Woetmann A; Ralfkiaer E; Iversen L; Odum N
Oncotarget; 2016 Jul; 7(29):45730-45744. PubMed ID: 27329723
[TBL] [Abstract][Full Text] [Related]
2. Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines.
Litvinov IV; Cordeiro B; Fredholm S; Ødum N; Zargham H; Huang Y; Zhou Y; Pehr K; Kupper TS; Woetmann A; Sasseville D
Cell Cycle; 2014; 13(18):2975-82. PubMed ID: 25486484
[TBL] [Abstract][Full Text] [Related]
3. Th17 cytokine differentiation and loss of plasticity after SOCS1 inactivation in a cutaneous T-cell lymphoma.
Ehrentraut S; Schneider B; Nagel S; Pommerenke C; Quentmeier H; Geffers R; Feist M; Kaufmann M; Meyer C; Kadin ME; Drexler HG; MacLeod RA
Oncotarget; 2016 Jun; 7(23):34201-16. PubMed ID: 27144517
[TBL] [Abstract][Full Text] [Related]
4. Keratinocytes Present Staphylococcus aureus Enterotoxins and Promote Malignant and Nonmalignant T Cell Proliferation in Cutaneous T-Cell Lymphoma.
Zeng Z; Vadivel CK; Gluud M; Namini MRJ; Yan L; Ahmad S; Hansen MB; Coquet J; Mustelin T; Koralov SB; Bonefeld CM; Woetmann A; Geisler C; Guenova E; Kamstrup MR; Litman T; Gjerdrum LR; Buus TB; Ødum N
J Invest Dermatol; 2024 May; ():. PubMed ID: 38762064
[TBL] [Abstract][Full Text] [Related]
5. Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis.
Genovese MC; van Vollenhoven RF; Wilkinson B; Wang L; Zwillich SH; Gruben D; Biswas P; Riese R; Takiya L; Jones TV
Arthritis Res Ther; 2016 Jun; 18():145. PubMed ID: 27334658
[TBL] [Abstract][Full Text] [Related]
6. Investigating potential exogenous tumor initiating and promoting factors for Cutaneous T-Cell Lymphomas (CTCL), a rare skin malignancy.
Litvinov IV; Shtreis A; Kobayashi K; Glassman S; Tsang M; Woetmann A; Sasseville D; Ødum N; Duvic M
Oncoimmunology; 2016 Jul; 5(7):e1175799. PubMed ID: 27622024
[TBL] [Abstract][Full Text] [Related]
7. SATB1 in Malignant T Cells.
Fredholm S; Willerslev-Olsen A; Met Ö; Kubat L; Gluud M; Mathiasen SL; Friese C; Blümel E; Petersen DL; Hu T; Nastasi C; Lindahl LM; Buus TB; Krejsgaard T; Wasik MA; Kopp KL; Koralov SB; Persson JL; Bonefeld CM; Geisler C; Woetmann A; Iversen L; Becker JC; Ødum N
J Invest Dermatol; 2018 Aug; 138(8):1805-1815. PubMed ID: 29751003
[TBL] [Abstract][Full Text] [Related]
8. Curcumin in treatment of hematological cancers: Promises and challenges.
Entezari M; Tayari A; Paskeh MDA; Kheirabad SK; Naeemi S; Taheriazam A; Dehghani H; Salimimoghadam S; Hashemi M; Mirzaei S; Samarghandian S
J Tradit Complement Med; 2024 Mar; 14(2):121-134. PubMed ID: 38481552
[TBL] [Abstract][Full Text] [Related]
9. miRNA Signature in Early-stage Mycosis Fungoides.
Sørensen ST; Litman T; Gluud M; Celis P; Torres-Rusillo S; Willerslev-Olsen A; Ødum N; Iversen L; Lindahl LM
Acta Derm Venereol; 2022 Oct; 102():adv00785. PubMed ID: 35788691
[TBL] [Abstract][Full Text] [Related]
10. MiR-130a-3p Alleviates Inflammatory and Fibrotic Phases of Pulmonary Fibrosis Through Proinflammatory Factor TNF-α and Profibrogenic Receptor TGF-βRII.
Ding Y; Hou Y; Liu Y; Yu T; Cui Y; Nie H
Front Pharmacol; 2022; 13():863646. PubMed ID: 35431964
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Distinct miRNA Regulatory Network in the Tumor Microenvironment of Transformed Mycosis Fungoides.
Di Raimondo C; Han Z; Su C; Wu X; Qin H; Sanchez JF; Yuan YC; Martinez X; Abdulla F; Zain J; Chen CW; Rosen ST; Querfeld C
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34831008
[TBL] [Abstract][Full Text] [Related]
12. Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers.
Li B; Wan Q; Li Z; Chng WJ
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680295
[TBL] [Abstract][Full Text] [Related]
13. Targeting JAK/STAT Signaling Antagonizes Resistance to Oncolytic Reovirus Therapy Driven by Prior Infection with HTLV-1 in Models of T-Cell Lymphoma.
Islam S; Espitia CM; Persky DO; Carew JS; Nawrocki ST
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372612
[TBL] [Abstract][Full Text] [Related]
14. Jak-STAT Inhibition Mediates Romidepsin and Mechlorethamine Synergism in Cutaneous T-Cell Lymphoma.
Cortes JR; Patrone CC; Quinn SA; Gu Y; Sanchez-Martin M; Mackey A; Cooke AJ; Shih BB; Laurent AP; Trager MH; Ferrando AA; Geskin LJ; Palomero T
J Invest Dermatol; 2021 Dec; 141(12):2908-2920.e7. PubMed ID: 34089720
[TBL] [Abstract][Full Text] [Related]
15. Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors-A Strategy for Hematological Malignancies?
Klein K; Stoiber D; Sexl V; Witalisz-Siepracka A
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34073410
[TBL] [Abstract][Full Text] [Related]
16. Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53.
Fan K; Spassova I; Gravemeyer J; Ritter C; Horny K; Lange A; Gambichler T; Ødum N; Schrama D; Schadendorf D; Ugurel S; Becker JC
Oncogene; 2021 Feb; 40(5):980-996. PubMed ID: 33311552
[TBL] [Abstract][Full Text] [Related]
17. The NKL-code for innate lymphoid cells reveals deregulated expression of NKL homeobox genes HHEX and HLX in anaplastic large cell lymphoma (ALCL).
Nagel S; Pommerenke C; MacLeod RAF; Meyer C; Kaufmann M; Drexler HG
Oncotarget; 2020 Aug; 11(34):3208-3226. PubMed ID: 32922661
[TBL] [Abstract][Full Text] [Related]
18. Hypopigmented Mycosis Fungoides: Loss of Pigmentation Reflects Antitumor Immune Response in Young Patients.
Martínez Villarreal A; Gantchev J; Lagacé F; Barolet A; Sasseville D; Ødum N; Charli-Joseph YV; Hernández Salazar A; Litvinov IV
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32707930
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-106b Regulates Expression of the Tumour Suppressors p21 and TXNIP and Promotes Tumour Cell Proliferation in Mycosis Fungoides.
Lindahl LM; Gluud M; Emmanuel T; Thomsen EA; Hu T; Rittig AH; Celis P; Stolearenco V; Krejsgaard T; Johansen C; Willerslev-Olsen A; Buus TB; Woetmann A; Aagaard L; Geisler C; Litman T; Mikkelsen JG; Odum N; Iversen L
Acta Derm Venereol; 2020 Sep; 100(16):adv00270. PubMed ID: 32556351
[TBL] [Abstract][Full Text] [Related]
20. JAK inhibition synergistically potentiates BCL2, BET, HDAC, and proteasome inhibition in advanced CTCL.
Yumeen S; Mirza FN; Lewis JM; King ALO; Kim SR; Carlson KR; Umlauf SR; Surovtseva YV; Foss FM; Girardi M
Blood Adv; 2020 May; 4(10):2213-2226. PubMed ID: 32437546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
